Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions

Recruiting Observational Study
Non Small Cell Lung Cancer Pulmonary Stereotactic Radiotherapy
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
150 (estimated)
Sponsor
Istituto Clinico Humanitas · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Radiotherapy (radiation treatment) is often used to treat lung cancers and lung tumors that have spread from other cancers. It can be very effective, especially in early-stage lung cancer or when there are only a few tumor sites. Even so, some patients later develop a local recurrence, meaning the cancer comes back in the same area that was previously treated with radiation. When this happens, tr…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Inoperable primary non-small cell lung cancer or other metastatic primaries with lung metastases, already treated with radical dose SBRT * Inoperable local recurrence (defined as a tumor recurrence overlapping the 50% isodose field) confirmed by documented radiographic finding…
Contacts

Davide Franceschini, MD, radiation oncologist

+39 0282247428

davide.franceschini@cancercenter.humanitas.it

CONTACT

Laura Bonavita, master degree

+39 0282247026

laura.bonavita@humanitas.it

CONTACT